Ewing's Sarcoma (ES) Recruiting Phase 2 Trials for Cabozantinib (DB08875)

Also known as: Ewing's Sarcoma / Ewing sarcoma / Ewings Sarcoma / Sarcoma, Ewing's / Sarcoma, Ewing / Sarcoma, Ewings / Ewing's sarcoma NOS / Ewing's sarcoma stage unspecified / Ewing's tumor / Ewing's tumour

IndicationStatusPhase
DBCOND0086609 (Ewing's Sarcoma (ES))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02867592Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare TumorsTreatment